BBIO Competitors & Alternatives
Compare BridgeBio Pharma Inc with similar stocks in the same industry
Biotechnology
BBIO
Main Stock$68.56
Tradestie Score
58
Market Cap
$10.22B
Revenue Growth
1.2%
Analyst Upside
+57.3%
Top Competitors
217 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
INCY
Incyte Genomics Inc
|
$115.71
|
$16.93B | 14.9 | 69 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$63.86
|
$15.70B | 33.9 | 49 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$15.47
|
$15.22B | - | 52 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$243.37
|
$12.36B | 18.3 | 51 | Compare |
|
EXEL
Exelixis Inc
|
$64.53
|
$11.09B | 20.6 | 29 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$36.49
|
$10.76B | - | 57 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$200.10
|
$10.74B | - | 41 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$55.95
|
$10.53B | 153.1 | 73 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$42.93
|
$10.49B | - | 61 | Compare |
|
MDGL
Madrigal Pharmaceuticals, Inc. Common Stock
|
$434.24
|
$10.01B | - | 48 | Compare |
More BBIO Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2834)
217 stocks in this industry